Walleye Capital
GH icon

Walleye Capital’s Guardant Health GH Stock Holding History

Walleye Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$554K Sell
6,000
-2,600
-30% -$261K ﹤0.01% 2584
2025
Q4 		$878K Sell
8,600
-11,800
-58% -$1.06M ﹤0.01% 2549
2025
Q3 		$1.27M Buy
20,400
+15,300
+300% +$832K ﹤0.01% 1908
2025
Q2 		$265K Buy
5,100
+4,500
+750% +$201K ﹤0.01% 3154
2025
Q1 		$25.6K Sell
600
-6,100
-91% -$263K ﹤0.01% 3973
2024
Q4 		$205K Sell
6,700
-2,400
-26% -$67.5K ﹤0.01% 3743
2024
Q3 		$209K Sell
9,100
-3,800
-29% -$108K ﹤0.01% 3979
2024
Q2 		$373K Sell
12,900
-6,500
-34% -$151K ﹤0.01% 3765
2024
Q1 		$400K Buy
19,400
+8,600
+80% +$184K ﹤0.01% 3400
2023
Q4 		$292K Sell
10,800
-4,900
-31% -$129K ﹤0.01% 3385
2023
Q3 		$465K Sell
15,700
-3,900
-20% -$137K ﹤0.01% 2877
2023
Q2 		$702K Sell
19,600
-7,300
-27% -$210K ﹤0.01% 2164
2023
Q1 		$631K Buy
26,900
+25,500
+1,821% +$728K 0.01% 1516
2022
Q4 		$38.1K Sell
1,400
-1,400
-50% -$64.1K ﹤0.01% 2579
2022
Q3 		$151K Buy
+2,800
New +$144K ﹤0.01% 2249
2020
Q1 		– Sell
-5,600
Closed -$438K – 1200
2019
Q4 		$438K Buy
5,600
+400
+8% +$28.8K 0.03% 739
2019
Q3 		$332K Sell
5,200
-1,800
-26% -$159K 0.02% 943
2019
Q2 		$604K Buy
+7,000
New +$535K 0.07% 424

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's GH Position: Q1 2026 in Review

Walleye Capital increased its Guardant Health (GH) stake by 15% in Q1 2026, buying an estimated $3.78M and bringing the position to 291,926 shares worth $27M. The position accounts for 0.11% of the portfolio, ranked #118.

Walleye Capital first reported a position in GH in Q4 2019 and has held it in 18 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Walleye Capital held 291,926 shares of Guardant Health worth $27M as of Q1 2026.
  • Walleye Capital bought 37,624 Guardant Health shares in Q1 2026, an estimated $3.78M.
  • Guardant Health made up 0.11% of Walleye Capital's portfolio in Q1 2026, its #118 holding.
  • Walleye Capital first reported a position in Guardant Health in Q4 2019 and has held it in 18 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.